Suchergebnisse - "Kato, Terufumi"

PubPharm (243)

1

Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis

enthalten in: Annals of the American Thoracic Society | 2024

von Ikeda, S. | Ogura, T. | Kato, T. | +14

2

Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop : Results from LC-SCRUM-Asia

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Okahisa, M. | Udagawa, H. | Matsumoto, S. | +24

3

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

enthalten in: The New England journal of medicine | 2024

von Wu, Y. | Dziadziuszko, R. | Ahn, J. | +120

4

Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study

enthalten in: Cancer science | 2024

von Morise, M. | Kato, T. | Matsumoto, S. | +15

5

Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION

enthalten in: British journal of cancer | 2024

von Kato, T. | Yang, J. | Ahn, M. | +14

6

Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis

enthalten in: Cancer medicine | 2024

von Murakami, S. | Shinada, K. | Otsutsumi, Y. | +8

7

Summary of Research : Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2024

von Tsuboi, M. | Herbst, R. | John, T. | +18

8

Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study

enthalten in: JTO clinical and research reports | 2024

von Teraoka, S. | Hayashi, H. | Goto, Y. | +8

9

CNS Efficacy of Osimertinib With or Without Chemotherapy in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small-Cell Lung Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Jänne, P. | Planchard, D. | Kobayashi, K. | +22

10

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2024

von Tsuboi, M. | Herbst, R. | John, T. | +18

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]